{
    "Case 1": {
        "1": {
            "question": "Describe the patient personal information.",
            "answer": "A 36-year-old male doctor with no underlying medical illness or allergies was administered the first dose of the COVID-19 vaccine (Cominarty, BNT162b2, Pfizer-BioNTech) in a tertiary hospital in Malaysia.",
            "cleaned_answer": [
                "A 36-year-old male doctor with no underlying medical illness or allergies was administered the first dose of the COVID-19 vaccine (Cominarty, BNT162b2, Pfizer-BioNTech) in a tertiary hospital in Malaysia."
            ]
        },
        "2": {
            "question": "Describe the patient experience.",
            "answer": "He presented to the ophthalmology clinic with left eye metamorphopsia 10 days after vaccination. He claimed to have bilateral metamorphopsia with generalized body aches about 3 h postvaccination. His myalgia and backache resolved after 1 day, and his right eye metamorphopsia resolved after 3 days. However, the metamorphopsia in his left eye persisted. Prior to this episode, he did not have any ocular symptoms.",
            "cleaned_answer": [
                "He presented to the ophthalmology clinic with left eye metamorphopsia 10 days after vaccination.",
                "He claimed to have bilateral metamorphopsia with generalized body aches about 3 h postvaccination.",
                "His myalgia and backache resolved after 1 day, and his right eye metamorphosia resolved after 3 days.",
                "However, the metamorphopsia in his left eye persisted.",
                "Prior to this episode, he did not have any ocular symptoms."
            ]
        },
        "3": {
            "question": "Did you notice any symptoms, such as a fever, cough, or respiratory issues?",
            "answer": "No viral-like illness or symptoms, such as cough, upper respiratory tract illness, or fever, were reported before or after his vaccination.",
            "cleaned_answer": [
                "No viral-like illness or symptoms, such as cough, upper respiratory tract illness, or fever, were reported before or after his vaccination."
            ]
        },
        "4": {
            "question": "What’s imaging (only provided the figure explanation here) suggest?",
            "answer": "(A)Fundus photograph, autofluorescence and ocular coherence tomography findings at 10 days post vaccination. There is left eye yellowish raised elevation and hyperautofluorescence at the fovea with dome-shaped elevation of the RPE at the fovea causing disruption of the ellipsoid zone. No subretinal fluid was noted.(B)Fundus photograph, ocular coherence tomography (OCT), fundus fluorescein angiography (FFA) and indocyanine green angiography (ICGA) of the same patient at 15 days post vaccination showed improvement clinically. The yellowish elevated lesion at the fovea had reduced in size, corresponding to the reported improvement in symptoms. The lesion from OCT was still present. There was hyperfluroescence at the macula in venous phase of FFA and hypocyanescence at the macula on ICGA.",
            "cleaned_answer": [
                "(A)Fundus photograph, autofluorescence and ocular coherence tomography findings at 10 days post vaccination.",
                "There is left eye yellowish raised elevation and hyperautofluorescence at the fovea with dome-shaped elevation of the RPE at the fovea causing disruption of the ellipsoid zone.",
                "No subretinal fluid was noted.",
                "(B)Fundus photograph, ocular coherence tomography (OCT), fundus fluorescein angiography (FFA) and indocyanine green angiography (ICGA) of the same patient at 15 days post vaccination showed improvement clinically.",
                "The yellowish elevated lesion at the fovea had reduced in size, corresponding to the reported improvement in symptoms.",
                "The lesion from OCT was still present.",
                "There was hyperfluroescence at the macula in venous phase of FFA and hypocyanescence at the macula on ICGA."
            ]
        },
        "5": {
            "question": "What’s examination suggest?",
            "answer": "Ocular imaging, including spectral-domain OCT, fundus photography, and autofluorescence, was obtained via Heidelberg Spectralis®HRA+OCT (Heidelberg Engineering, Heidelberg, Germany), which showed a dome-shaped hyper-reflective elevation at the left fovea involving the photoreceptor layer and causing disruption of the ellipsoid zone. Fundus autofluorescence showed hyperautofluorescence at the foveal region that corresponded clinically to the location where the yellowish-white lesion was observed at the macula (Figure 1A). These findings were suggestive of acute retinal pigment epithelitis (ARPE).",
            "cleaned_answer": [
                "Ocular imaging, including spectral-domain OCT, fundus photography, and autofluorescence, was obtained via Heidelberg Spectralis®HRA+OCT (Heidelberg Engineering, Heidelberg, Germany), which showed a dome-shaped hyper-reflective elevation at the left fovea involving the photoreceptor layer and causing disruption of the ellipsoid zone.",
                "Fundus autofluorescence showed hyperautofluorescence at the foveal region that corresponded clinically to the location where the yellowish-white lesion was observed at the macula (Figure 1A).",
                "These findings were suggestive of acute retinal pigment epithelitis (ARPE)."
            ]
        },
        "6": {
            "question": "Is any suggestions?",
            "answer": "We diagnosed his ocular symptoms as possibly vaccine-related, and our patient subsequently opted not to continue with the second dose of his vaccine.”",
            "cleaned_answer": [
                "We diagnosed his ocular symptoms as possibly vaccine-related, and our patient subsequently opted not to continue with the second dose of his vaccine.”"
            ]
        }
    },
    "Case 2": {
        "1": {
            "question": "Describe the patient personal information.",
            "answer": "A 68-year-old Malay man.",
            "cleaned_answer": [
                "A 68-year-old Malay man."
            ]
        },
        "2": {
            "question": "Describe the patient experience.",
            "answer": "Presented with sudden-onset right-eye central blurring of vision 3 days after receiving his second dose of COVID-19 vaccination (Cominarty, BNT162b2, Pfizer-BioNTech). He had no underlying medical illness and no significant past ocular history. He did not have any ocular symptoms after his first dose of the vaccine.",
            "cleaned_answer": [
                "A 68-year-old Malay man presented with sudden-onset right-eye central blurring of vision 3 days after receiving his second dose of COVID-19 vaccination (Cominarty, BNT162b2, Pfizer-BioNTech).",
                "He had no underlying medical illness and no significant past ocular history.",
                "He did not have any ocular symptoms after his first dose of the vaccine."
            ]
        },
        "3": {
            "question": "Did you notice any symptoms, such as a fever, cough, or respiratory issues?",
            "answer": "$No$",
            "cleaned_answer": [
                "He had no underlying medical illness and no significant past ocular history."
            ]
        },
        "4": {
            "question": "What’s imaging (only provided the figure explanation here) suggest?",
            "answer": "Ocular coherence tomography (Topcon Spectral Domain OCT) showed loss of foveal contour with the presence of intraretinal and subretinal fluid, and a fibrovascular pigment epithelial defect (Figure 2A). OCT macula revealed resolution of intraretinal fluids; however, the subretinal fluid was similar in size and the fibrovascular PED was more defined (Figure 2B).",
            "cleaned_answer": [
                "Ocular coherence tomography (Topcon Spectral Domain OCT) showed loss of foveal contour with the presence of intraretinal and subretinal fluid, and a fibrovascular pigment epithelial defect (Figure 2A).",
                "OCT macula revealed resolution of intraretinal fluids; however, the subretinal fluid was similar in size and the fibrovascular PED was more defined (Figure 2B)."
            ]
        },
        "5": {
            "question": "What’s examination suggest?",
            "answer": "His presenting visual acuity was 6/12 OD and 6/6 OS. The anterior segment examination was unremarkable. Fundus examination showed an orange-round lesion at the macula. There was no drusen or evidence of age-related macular degeneration, and no myopic changes. Examination of the posterior segment showed hemorrhagic changes at the macula.",
            "cleaned_answer": [
                "His presenting visual acuity was 6/12 OD and 6/6 OS.",
                "The anterior segment examination was unremarkable.",
                "Fundus examination showed an orange-round lesion at the macula.",
                "There was no drusen or evidence of age-related macular degeneration, and no myopic changes.",
                "Examination of the posterior segment showed hemorrhagic changes at the macula."
            ]
        },
        "6": {
            "question": "Is any suggestions?",
            "answer": "$No$”",
            "cleaned_answer": [
                "He had no underlying medical illness and no significant past ocular history."
            ]
        }
    },
    "Case 3": {
        "1": {
            "question": "",
            "answer": "A 50-year-old Malay woman with no underlying medical illness presented with bilateral blurring of vision 2 weeks after receiving her second dose of COVID-19 vaccination (Cominarty, BNT162b2, Pfizer-BioNTech).",
            "cleaned_answer": [
                "A 50-year-old Malay woman with no underlying medical illness presented with bilateral blurring of vision 2 weeks after receiving her second dose of COVID-19 vaccination (Cominarty, BNT162b2, Pfizer-BioNTech)."
            ]
        },
        "2": {
            "question": "",
            "answer": "Her blurring of vision started 1 week after vaccination and did not improve over time.",
            "cleaned_answer": [
                "Her blurring of vision started 1 week after vaccination and did not improve over time."
            ]
        },
        "3": {
            "question": "",
            "answer": "$No$",
            "cleaned_answer": [
                "The anterior segment examination was unremarkable, with no evidence of anterior segment inflammation."
            ]
        },
        "4": {
            "question": "",
            "answer": "(A)Fundus photo and OCT macula showing bilateral placoid lesions in the choroid with macula edema on presentation.(B)Fundus photo and OCT macula showing resolution of bilateral placoid lesions and macula edema one week post-treatment with intravenous methylprednisolone.",
            "cleaned_answer": [
                "(A)Fundus photo and OCT macula showing bilateral placoid lesions in the choroid with macula edema on presentation.",
                "(B)Fundus photo and OCT macula showing resolution of bilateral placoid lesions and macula edema one week post-treatment with intravenous methylprednisolone."
            ]
        },
        "5": {
            "question": "",
            "answer": "Posterior segment examination showed bilateral fibrinous placoid lesions in the choroid with severe inner and outer macula edema (Figure 3A).",
            "cleaned_answer": [
                "Posterior segment examination showed bilateral fibrinous placoid lesions in the choroid with severe inner and outer macula edema (Figure 3A)."
            ]
        },
        "6": {
            "question": "",
            "answer": "A diagnosis of acute multifocal placoid pigment epitheliopathy was made based on clinical and investigational findings.”",
            "cleaned_answer": [
                "A diagnosis of acute multifocal placoid pigment epitheliopathy was made based on clinical and investigational findings.”"
            ]
        }
    },
    "Case 4": {
        "1": {
            "question": "Describe the patient personal information.",
            "answer": "A 32-year-old Malay woman who is a housewife with an underlying history of anxiety, panic disorder, and depression.",
            "cleaned_answer": [
                "A 32-year-old Malay woman who is a housewife with an underlying history of anxiety, panic disorder, and depression."
            ]
        },
        "2": {
            "question": "Describe the patient experience.",
            "answer": "She received her first dose of Oxford AstraZeneca ChAdOx1 COVID-19 vaccination. Two weeks after her vaccination, she developed multiple skin rashes, vesicles, and crusty lesions over the right side of her face, respecting the midline and involving the tip of the nose. A week later, following the onset of the rash, she developed sudden-onset redness, itchiness, and mild blurring of vision in her right eye. There was also right periorbital swelling, which resolved after 2 days.",
            "cleaned_answer": [
                "A 32-year-old Malay woman who is a housewife with an underlying history of anxiety, panic disorder, and depression received her first dose of Oxford AstraZeneca ChAdOx1 COVID-19 vaccination.",
                "Two weeks after her vaccination, she developed multiple skin rashes, vesicles, and crusty lesions over the right side of her face, respecting the midline and involving the tip of the nose.",
                "A week later, following the onset of the rash, she developed sudden-onset redness, itchiness, and mild blurring of vision in her right eye.",
                "There was also right periorbital swelling, which resolved after 2 days."
            ]
        },
        "3": {
            "question": "Did you notice any symptoms, such as a fever, cough, or respiratory issues?",
            "answer": "$No$",
            "cleaned_answer": [
                "$No$"
            ]
        },
        "4": {
            "question": "What’s imaging (only provided the figure explanation here) suggest?",
            "answer": "$No$",
            "cleaned_answer": [
                "$No$"
            ]
        },
        "5": {
            "question": "What’s examination suggest?",
            "answer": "Her visual acuity was 6/12 unaided and 6/6 pinhole OU. An ocular examination showed the presence of a circumciliary injection in her right eye. Corneal sensation was intact and equal bilaterally. There was no evidence of cornea epithelial, stromal, or endothelial involvement. Intraocular pressure was 14 mmHg OU. The anterior chamber showed cell activity at 2+ with no keratic precipitates, hypopyons, or fibrinous reactions. Fundus examination was otherwise unremarkable, with normal optic disc and macula. There was no evidence of posterior segment inflammation such as vitritis, retinitis, choroiditis, or vasculitis. Examination of the left eye was normal.",
            "cleaned_answer": [
                "Her visual acuity was 6/12 unaided and 6/6 pinhole OU.",
                "An ocular examination showed the presence of a circumciliary injection in her right eye.",
                "Corneal sensation was intact and equal bilaterally.",
                "There was no evidence of cornea epithelial, stromal, or endothelial involvement.",
                "Intraocular pressure was 14 mmHg OU.",
                "The anterior chamber showed cell activity at 2+ with no keratic precipitates, hypopyons, or fibrinous reactions.",
                "Fundus examination was otherwise unremarkable, with normal optic disc and macula.",
                "There was no evidence of posterior segment inflammation such as vitritis, retinitis, choroiditis, or vasculitis.",
                "Examination of the left eye was normal."
            ]
        },
        "6": {
            "question": "Is any suggestions?",
            "answer": "$No$”",
            "cleaned_answer": [
                "$No$”"
            ]
        }
    }
}